{"id":"W2322556147","doi":"10.1093/neuonc/nou258.26","title":"IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Oncology; Epidermal growth factor receptor; Progressive disease; Gastroenterology; Cancer; Radiation therapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004828557,0.0003216174,0.0002453608,0.0001140333,0.0001453497,0.0002673772,0.00019469,0.0003591264,0.0005534526],"category_scores_gemma":[0.0003315077,0.00006652631,0.0002168866,0.0001183291,0.0002305944,0.0002816702,0.0001639677,0.0005665964,0.00026005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002185513,"about_ca_system_score_gemma":0.0001922007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003491148,"about_ca_topic_score_gemma":0.0003394963,"domain_scores_codex":[0.9998779,0.00005502006,0.000007213799,0.00001558844,0.00001373751,0.00003051945],"domain_scores_gemma":[0.999892,0.00003120826,0.00001558159,0.000009867505,0.00001462251,0.00003664527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007306791,0.005632091,0.01109281,0.0002190041,0.0001457066,0.002226638,0.0008061664,0.001518625,0.08607603,0.0006964178,0.004758762,0.8795211],"study_design_scores_gemma":[0.01014437,0.4052984,0.1653468,0.0005302251,0.0005919298,0.02549858,0.0008209218,0.009292249,0.1654257,0.002659433,0.2142563,0.0001350883],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885941,0.004597051,0.001672939,0.0006701545,0.00007603283,0.0001288332,0.00005647662,0.00004730428,0.004157088],"genre_scores_gemma":[0.9905025,0.005145357,0.001357912,0.001019331,0.00009793202,0.00006824986,0.0002909649,0.00002736875,0.001490519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005534526,"threshold_uncertainty_score":0.002553642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0259800437965206,"score_gpt":0.2979942413213975,"score_spread":0.2720141975248769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}